Tandem Repeats (CCTTT)n in the Promoter of iNOS Gene in Korean Genome

  • ;
  • 유민 (계명대학교 생물학과)
  • Baek, Sun-Ah (Department of Biology, Keimyung University) ;
  • Yoo, Min (Department of Biology, Keimyung University)
  • 발행 : 2009.06.30

초록

Nitric oxide is an important factor to regulate the biochemical reactions in the body such as expansion of blood vessel, neural conduction and antimicrobial activity. There are two forms of nitric oxide synthase and iNOS has attracted most attention because it is involved in the development of diabetes and cardiac disease condition. There are several regulatory sequences in the promoter region of iNOS gene. One of them is (CCTTT)n. It has been reported that the number of tandem repeat of (CCTTT)n varies from population to population. So, we analyzed (CCTTT)n polymorphism in Korean genome for the purpose of comparison. According to our present study Koreans are different from other Asians reported previously because $(CCTTT)_{10}$ is the highest incidence as opposed to $(CCTTT)_{12}$ for other countries. This study should facilitate the understanding of the expression of iNOS gene in different population.

키워드

참고문헌

  1. Baik SW, Song SK, Kim HK, Kwon JY, Shin SW. The effect of isoflurane on the expression of iNOS mRNA in endotoxemic rats. Kor J Anesthesiol. 2000. 38: 1047-1053. https://doi.org/10.4097/kjae.2000.38.6.1047
  2. Bardell AL, Macleod KM. Evidence for inducible nitric-oxide synthase-expression and activity in vascular smooth muscle of streptozotocin diabetic rats. J pharmacol Exp Ther. 2001. 296: 252-259.
  3. Chio KH, Noh HJ, Kim BS, Kang SW, Han DS, Lee HY. Inducible nitric oxide synthase (iNOS) is increased in diabetic rat glomeruli: role of angiotensin II (AII). The Kor J Nephrol. 2003. 22: 366-373.
  4. Chiou WF, Chou CJ, Chen CF. Camptothecin suppresses nitric oxide biosynthesis in RAW 264.7 macrophages. Life Sci. 2001. 69: 625-635. https://doi.org/10.1016/S0024-3205(01)01154-7
  5. Lee HR, Yoo M. Polymorphism of KCNE1 Gene in Korean Population. J Exp Biomed Sci. 2008. 14: 123-126.
  6. Johannesen J, Tarnow L, Parving H, Nerup J, Pociot F. CCTTTrepeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care 2000. 23: 560-562. https://doi.org/10.2337/diacare.23.4.560
  7. Kuo ML, Chau YP, Wang JH, Shiah SG. Inhibitors of Poly (ADP-ribose) polymerase block nitric oxide-induced apoptosis but not different in human leukemia HL-60 Cells. Biochem Biophys Res Commun. 1996. 219: 502-508. https://doi.org/10.1006/bbrc.1996.0263
  8. Lee KY. The pathophysiological roles and clinical implications in circulatory system. The YongNam Univ Mad J. 1996. 13: 159-172. https://doi.org/10.12701/yujm.1996.13.2.159
  9. Liao L, Lim MC, Chan SW, Zhao JJ, Lee KO. Nitric oxide synthase gene polymorphisms and nephropathy in asians with type 2 diabetes. J Diabetes Complications 2005. 20: 371-375. https://doi.org/10.1016/j.jdiacomp.2005.10.006
  10. Martin J, Paco L, Ruiz MP, Lopez-Nevot MA, Garcia-Porrua C, Amoli MM, Calvino MC, Ollier WER, Gonzalez-Gay. Inducible nitric oxide synthase polymorphism is associated with susceptibility to henoch-schonlein purpura in northwestern spain. J Rheumatol. 2005. 32: 1081-1085.
  11. Seo WG, Pae HO, Oh GS, Chai KY, Yun YG, Kwon TO, Chung HT. Inhibitory effect of ethyl acetate fraction from Cudrania tricuspidata on the expression of nitric oxide synthase gene in RAW 264.7 macrophages stimulated with interferon-and lipopolysaccharide. Gen Pharmacol. 2000. 35: 21-28. https://doi.org/10.1016/S0306-3623(01)00086-6